High plasma mid-regional pro-adrenomedullin levels in children with severe dengue virus infections

被引:19
|
作者
Michels, Meta [1 ]
Djamiatun, Kis [2 ,3 ]
Faradz, Sultana M. H. [3 ,4 ]
Koenders, Mieke M. J. F. [5 ]
de Mast, Quirijn [1 ]
van der Ven, Andre J. A. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Diponegoro Univ, Dr Kariadi Hosp, Dept Parasitol, Semarang, Indonesia
[3] Diponegoro Univ, Fac Med, Semarang, Indonesia
[4] Diponegoro Univ, Dr Kariadi Hosp, Div Human Genet, Ctr Biomed Res, Semarang, Indonesia
[5] St Elizabeth Hosp, Dept Clin Chem & Hematol, Tilburg, Netherlands
关键词
Dengue hemorrhagic fever/dengue shock syndrome; Biomarkers; Adrenomedullin; Mid regional pro adrenomedullin; Vasopressin; Copeptin; BINDING PROTEIN-1; SEPSIS; COPEPTIN; VASOPRESSIN; MECHANISMS; PRECURSOR; PEPTIDE; ASSAY;
D O I
10.1016/j.jcv.2010.09.008
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) is characterized by hemorrhage, plasma leakage and shock. Adrenomedullin and vasopressin are vaso-active hormones that mediate endothelial permeability, vascular tone and water balance and may therefore play a role during DHF/DSS. Adrenomedullin reduces endothelial permeability and has vasodilatory properties, while vasopressin is a potent vasoconstrictor with anti-diuretic effects. Objectives: To determine mid-regional pro-adrenomedullin (MR-proADM) and copeptin, which are reliable and stable markers for adrenomedullin and vasopressin response, respectively, and relate their plasma concentrations to outcome and markers of plasma leakage in Indonesian children with DHF and DSS. Study design: In this observational cohort study Indonesian children with DHF/DSS were enrolled. On study days 0 and 2, plasma MR-proADM and copeptin concentrations as well as parameters of plasma leakage were determined. Plasma MR-proADM and copeptin concentrations were compared to values of healthy controls. Results: MR-proADM was increased in both DHF (n = 43) and DSS (n = 28) vs. controls (n = 17), with median (IQR) values of 0.47 (0.40-0.68), 0.56 (0.44-1.00) vs. 0.22 (0.19-0.29) nmol/L, respectively. Additionally, MR-proADM correlated with signs of increased vascular leakage such as low albumin and increased pleural effusion. Copeptin concentrations showed no significant changes as compared to controls. Conclusions: MR-proADM concentrations are elevated in children with DHF and DSS and correlate with the severity of plasma leakage, in contrast to copeptin concentrations. We speculate that adrenomedullin has a functional role in limiting endothelial hyperpermeability during DHF/DSS. Finally, MR-proADM may be a candidate biomarker to predict development of DHF/DSS. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:8 / 12
页数:5
相关论文
共 50 条
  • [41] Mid-regional pro-adrenomedullin predicts poor outcome in non-selected patients admitted to an intensive care unit
    Bellia, Chiara
    Agnello, Luisa
    Lo Sasso, Bruna
    Bivona, Giulia
    Raineri, Maurizio Santi
    Giarratano, Antonino
    Ciaccio, Marcello
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (04) : 549 - 555
  • [42] Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure
    Gegenhuber, Alfons
    Struck, Joachim
    Dieplinger, Benjamin
    Poelz, Werner
    Pacher, Richard
    Morgenthaler, Nils G.
    Bergmann, Andreas
    Haltmayer, Meinhard
    Mueller, Thomas
    JOURNAL OF CARDIAC FAILURE, 2007, 13 (01) : 42 - 49
  • [43] Midregional pro-adrenomedullin plasma concentrations are blunted in severe preeclampsia
    Matson, B. C.
    Corty, R. W.
    Karpinich, N. O.
    Murtha, A. P.
    Valdar, W.
    Grotegut, C. A.
    Caron, K. M.
    PLACENTA, 2014, 35 (09) : 780 - 783
  • [44] Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial
    Moeckel, Martin
    Searle, Julia
    Hartmann, Oliver
    Anker, Stefan D.
    Peacock, W. Frank
    Wu, Alan H. B.
    Maisel, Alan
    EMERGENCY MEDICINE JOURNAL, 2013, 30 (08) : 633 - 637
  • [45] Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin
    Enguix-Armada, Alfredo
    Escobar-Conesa, Rocio
    Garcia-De La Torre, Angela
    Victoria De La Torre-Prados, Maria
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (01) : 163 - 168
  • [46] Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients
    Fialek, Bartosz
    De Roquetaillade, Charles
    Pruc, Michal
    Navolokina, Alla
    Chirico, Francesco
    Ladny, Jerzy Robert
    Peacock, Frank William
    Szarpak, Lukasz
    ANNALS OF MEDICINE, 2023, 55 (01) : 379 - 387
  • [47] Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study
    Pervez, Mohammad Osman
    Lyngbakken, Magnus Nakrem
    Myhre, Peder Langeland
    Brynildsen, Jon
    Langsjoen, Eva Camilla
    Hoiseth, Arne Didrik
    Christensen, Geir
    Omland, Torbjorn
    Rosjo, Helge
    CLINICAL BIOCHEMISTRY, 2017, 50 (7-8) : 394 - 400
  • [48] Correlation between Serum Mid-Regional Pro-Adrenomedullin and Sequential Organ Failure Assessment (SOFA) Score in Patient with Sepsis
    Pujiyanti, Hapsari
    Lismayanti, Leni
    Rostini, Tiene
    Parwati, Ida
    MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2019, 51 (02): : 118 - 121
  • [49] Comparison of presepsin and Mid-regional pro-adrenomedullin in the diagnosis of sepsis or septic shock: a systematic review and meta-analysis
    Liang, Jun
    Cai, Yingli
    Shao, Yiming
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [50] Prognostic utility of mid-regional pro-adrenomedullin and growth differentiation factor 15 in patients undergoing transfemoral transcatheter aortic valve implantation
    Piayda, Kerstin
    Keranov, Stanislav
    Schulz, Luisa
    Arsalan, Mani
    Liebetrau, Christoph
    Kim, Won-Keun
    Hofmann, Felsix J.
    Bauer, Pascal
    Voss, Sandra
    Troidl, Christian
    Sossalla, Samuel T.
    Hamm, Christian W.
    Nef, Holger M.
    Doerr, Oliver
    CLINICAL RESEARCH IN CARDIOLOGY, 2024,